Canada Pension Plan Investment Board acquired a new position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 2,019,301 shares of the company’s stock, valued at approximately $46,706,000.
Several other large investors have also recently modified their holdings of BBWI. Global Retirement Partners LLC acquired a new stake in Bath & Body Works in the fourth quarter valued at approximately $31,000. Activest Wealth Management purchased a new position in Bath & Body Works in the fourth quarter worth $32,000. Geneos Wealth Management Inc. increased its position in shares of Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after purchasing an additional 801 shares in the last quarter. Parallel Advisors LLC increased its position in shares of Bath & Body Works by 42.6% during the fourth quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after purchasing an additional 567 shares in the last quarter. Finally, Danske Bank A S purchased a new stake in shares of Bath & Body Works during the 3rd quarter valued at $39,000. Institutional investors own 95.14% of the company’s stock.
Bath & Body Works News Summary
Here are the key news stories impacting Bath & Body Works this week:
- Positive Sentiment: BBWI reported second-quarter adjusted EPS of $0.62, well above the $0.24 consensus estimate, while revenue of $1.51 billion modestly exceeded expectations. The earnings beat was supported by demand for body-care and home-fragrance products and improved digital sales. BBWI Stock Jumps 7.5% on Q2 Earnings Beat, Fiscal 2026 Outlook Raised
- Positive Sentiment: Management raised fiscal 2026 adjusted EPS guidance to $2.60-$2.80 from $2.40-$2.65 and projected revenue of $7.5-$7.6 billion. The company also cited progress in its transformation plan, with a goal of approximately $250 million in cost savings and stronger cash generation. Bath & Body Works lifts annual profit forecast
- Neutral Sentiment: Analysts remain divided after the results. Morgan Stanley reduced its price target to $20 from $22 while keeping an Equal Weight rating; UBS cut its target to $17 from $19 and maintained a Neutral rating. These targets suggest limited upside or downside from recent trading levels. Analyst price-target changes
- Negative Sentiment: Near-term performance remains pressured by weak store traffic and declining overall sales. Second-quarter revenue fell 2.3% year over year, and third-quarter adjusted EPS guidance of $0.07-$0.12 is substantially below the roughly $0.27 analyst consensus, raising concerns about promotional activity and continued softness in physical stores. Bath & Body Works results top expectations
Bath & Body Works Stock Down 1.2%
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its earnings results on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.38. The firm had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.50 billion. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%.The business’s revenue was down 2.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.30 earnings per share. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. As a group, equities analysts anticipate that Bath & Body Works, Inc. will post 2.67 EPS for the current fiscal year.
Bath & Body Works Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Friday, August 21st will be given a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date of this dividend is Friday, August 21st. Bath & Body Works’s payout ratio is presently 20.83%.
Analysts Set New Price Targets
A number of research firms have recently weighed in on BBWI. Weiss Ratings raised Bath & Body Works from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 9th. Morgan Stanley reduced their target price on Bath & Body Works from $22.00 to $20.00 and set an “equal weight” rating on the stock in a research report on Thursday. Jefferies Financial Group increased their price target on Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. Telsey Advisory Group lowered their price target on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating for the company in a report on Thursday, May 28th. Finally, Citigroup upgraded Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price target on the stock in a research note on Tuesday, August 18th. Four research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $22.29.
Read Our Latest Stock Analysis on BBWI
Bath & Body Works Profile
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Articles
- Five stocks we like better than Bath & Body Works
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
